Compiled by April Doster, G2Xchange Health
The G2Xchange Health Team sends out periodic surveys to our members. These brief, anonymous surveys give insight into our community’s thoughts on a variety of topics. One of our most recent surveys asked members to answer the following questions, regarding the Defense Health Agency. DHA continues to be in a state of flux, and post cancellation of DHA HITS Gen I, many firms are re-evaluating where they spend their time in 2016. Included here are results from a recent anonymous survey of Fed Health IT leaders.
Rate your current temperature (on a scale of 1-10) regarding perceived growth opportunity for IT and Consulting at DHA in 2016/17?
1- Ice cold (not a focus area) – 10 – Red Hot (Major Priority)
Note: The graph below shows the percentage of respondents who selected which rating.
Has the DHA/GSA relationship affected your near term BD Strategy?
Note: The graph below shows the percentage of respondents who selected Not at all, Some, or A lot.
Given the announcement of the DHA/GSA relationship and the forecast DHA released, how has your BD focus with regard to DHA changed moving forward?
Note: The graph below shows the percentage of respondents who selected Positively, Neutral, or Negatively.
Lastly, we asked respondents to provide three words or program names that dictate what the focus will or should be at DHA for 2016 and 2017.
Note: Responses are weighted, with higher frequency words larger than less frequent words.
Agree/Disagree with the results? Didn’t get a change to share your opinion? Comment below and let us know what you think.
